--- title: "URSA-PHARM | PDC Medication Adherence" slug: "pharm-reports-ursa-pharm-pdc-medication-adherence" updated: 2025-06-26T17:18:33Z published: 2025-06-26T17:18:33Z canonical: "docs.ursahealth.com/pharm-reports-ursa-pharm-pdc-medication-adherence" --- > ## Documentation Index > Fetch the complete documentation index at: https://docs.ursahealth.com/llms.txt > Use this file to discover all available pages before exploring further. # URSA-PHARM | PDC Medication Adherence ## Overview Proportion of Days Covered ("PDC") measures the percent of days during an medication therapy episode with a positive supply of across three major medication types which are tracked in CMS Stars ratings; Oral Antidiabetics, Oral ACEI/ARBs, and Statins. This report introduces users to the concept of PDC, provides versions of these measures that are geared towards practice operations, and contains pre-built boards that show performance across populations, payors, and action lists of patients currently failing to meet the PDC target of 80% of days within an episode. --- ## Use this report to - Develop an understanding of the configuration of a PDC measure - Analyze historical and monitor ongoing performance across PDCs for Oral Antidiabetics, Oral ACEI/ARBs, and Statins. - Generate lists of patients requiring intervention to meet their PDC target. - Measure the opportunity for deploying interventions such as 90-day fills to improve adherence. --- ## Potential takeaways - What is PDC performance across payors and plans? - Which patients are falling below 80% of PDC? - Which patients currently falling below 80% are redeemable for the 12 month measurement period? - Which patients have multiple open episodes? - Which providers are owning the prescriptions of these adherence medications? - Who is/are the providers prescribing the medications for this episode and is it the PCP or another provider? - What percent of PDC medications are being prescribed for a 90-day supply? - Which providers/patients could be switched to a 90-day supply?